Month: March 2026

Acquisition Provides Exposure to Emerging US Defense Technologies with Multi-Sector National Security Applications Roseland, NJ, March 03, 2026 (GLOBE NEWSWIRE) — Gaxos.ai Inc. (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various high-growth sectors, today announced that it acquired a 19.99% stake in America First Defense (“AFD”), a US-based defense technology company developing next-generation drone and robotics platforms. America First Defense is an American-owned defense technology company developing next-generation security platforms across both air and ground domains. The company is focused on two high-priority categories: a detachable counter-drone system designed to neutralize hostile UAVs through precise protocol-level cyber attacks without collateral...

WESTPORT, Conn., March 03, 2026 (GLOBE NEWSWIRE) — Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market branded businesses, announced today that, effective March 1, 2026, Mr. Eugene Kim and Mr. Glenn Richter have been elected to the Company’s Board of Directors (the “Board”). Mr. Alexander S. Bhathal resigned from the Board effective February 28, 2026, due to other commitments. Based on a recommendation from the Board’s Nominating & Corporate Governance Committee, the Board approved an increase in the number of directors serving on the Board from seven to eight, effective March 1, 2026. Messrs. Kim and Richter were elected to fill the vacancy resulting from Mr. Bhathal’s resignation and the newly created directorship. Mr. Kim has been appointed to serve on the Board’s Audit and Compensation...

Cumulatively Emerging US Markets represent 31% of Safe Harbor’s Total Deposit Balances Driven by Strategic Early Entry into High-Growth States Including New York, New Jersey, Illinois, Florida, Ohio, and Kentucky DENVER, March 03, 2026 (GLOBE NEWSWIRE) — SHF Holdings, Inc., d/b/a Safe Harbor (the “Company” or “Safe Harbor”) (NASDAQ: SHFS), a leading fintech platform serving the banking, lending, and financial services needs of the regulated cannabis and hemp industries, announced that emerging US market average deposit balances increased 29% over the 12 months ended February 4, 2026, driving total average deposit balances up 4.5%. Emerging US markets now represent 31% of the Company’s average deposit balances, with this growth reflecting Safe Harbor’s strategic focus on high-potential state markets. “We’ve built a strong...

Veteran business development leader with deep expertise in human-relevant NAM and spheroid-based in vitro services to spearhead commercial growth along the US East Coast, deepening VivoSim’s reach with biopharma innovators seeking human-relevant liver and GI toxicity solutions SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) — VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced the appointment of Dr. Arumugham (Ragoo) Raghunathan, PhD as Vice President of Global Sales. Based in the Greater Boston area, Dr. Raghunathan will lead commercial expansion and secure strategic partnerships with biopharma innovators, established pharmaceutical companies, CROs/CDMOs, and research institutions. His focus will be on delivering VivoSim’s...

SINGAPORE, March 03, 2026 (GLOBE NEWSWIRE) — Uni-Fuels Holdings Limited (NASDAQ: UFG) (“Uni-Fuels” or the “Company”), a global provider of marine fuel solutions headquartered in Singapore, today announced that its regional operating subsidiaries have expanded its bunkering operations across major and strategic marine fuel supply locations in Thailand, marking a significant milestone in the Company’s global growth strategy. This development represents an important advancement in Uni-Fuels’ next phase of global expansion. It reinforces the Company’s commitment to strengthening its presence across key maritime hubs while continuing to scale its international operations platform in a disciplined and value-accretive manner. Uni-Fuels now offers customers access to a nationwide bunkering network in Thailand spanning both the Gulf of...

Presentations include three-year follow-up data from patients receiving a one-time 50 milligram (mg) dose of lonvo-z and survey findings highlighting patients’ continued treatment burden and unmet needs CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced details about its presentation of four posters at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting (AAAAI) that took place this past weekend in Philadelphia, Pennsylvania. All posters are available on intelliatx.com on the Scientific Publications & Presentations page. Poster Presentation Details:Title: Long-Term Durability and Safety of Lonvoguran Ziclumeran...

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, March 10, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company’s website at http://www.siga.com in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921...

FORT WORTH, TX, March 03, 2026 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, announced today that it will report its fourth quarter and full year 2025 financial results on Tuesday, March 24, 2026 before the U.S. financial markets open. The Company will host a conference call and webcast on March 24, 2026 at 8:00 a.m. Eastern Time to discuss the results of the quarter and full year ended December 31, 2025 and hold a question and answer session at the end of the call. The toll-free number to call for this teleconference is 888-506-0062 (international callers: 973-528-0011) and the access code...